“…Since α- and non-α-mangostin xanthones have been shown to possess anti-bacterial activity, especially against Gram-positive bacteria [ 12 , 13 , 14 , 15 , 16 , 17 , 18 ], it is most probable that semi-synthetic analogs would be produced with enhanced anti-bacterial activity. In order to increase the bioactivity and antibacterial properties of α-mangostin, semi-synthetic modification of the compound was performed by several authors, to lead to more active compounds [ 25 , 26 , 27 , 28 , 29 ], with no excessive toxicity. Alongside their anti-microbial properties, the synthetic analogs possess wound healing and anti-inflammatory activity and, hence, they could be exploited in the treatment of skin infections.…”